Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Susanne Wilde"'
Autor:
Felix K M Lorenz, Susanne Wilde, Katrin Voigt, Elisa Kieback, Barbara Mosetter, Dolores J Schendel, Wolfgang Uckert
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121633 (2015)
Codon optimization of nucleotide sequences is a widely used method to achieve high levels of transgene expression for basic and clinical research. Until now, immunological side effects have not been described. To trigger T cell responses against huma
Externí odkaz:
https://doaj.org/article/1dc7330131824a3e95242ca3e8507f4b
Autor:
Elfriede Noessner, Gerald Willimsky, Wolfgang Uckert, Dolores J. Schendel, Susanne Wilde, Hartmann Harz, Heinrich Leonhardt, Peter J. Nelson, Svenja Rühland, Anja Disovic, Julia Schnappinger, Matthias Leisegang, Luis Felipe Olguín-Contreras, Ramona Schlenker
constructs, murine HCC model, spheroid and imaging, RCC tissue pathology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63554d2c22ce2fe4daadd9b9ceda6b8f
https://doi.org/10.1158/0008-5472.22414901.v1
https://doi.org/10.1158/0008-5472.22414901.v1
Autor:
Elfriede Noessner, Gerald Willimsky, Wolfgang Uckert, Dolores J. Schendel, Susanne Wilde, Hartmann Harz, Heinrich Leonhardt, Peter J. Nelson, Svenja Rühland, Anja Disovic, Julia Schnappinger, Matthias Leisegang, Luis Felipe Olguín-Contreras, Ramona Schlenker
Inherent intermediate- to low-affinity T-cell receptors (TCR) that develop during the natural course of immune responses may not allow sufficient activation for tumor elimination, making the majority of T cells suboptimal for adoptive T-cell therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb3a0482feb5d12f375a57e19ec5b20
https://doi.org/10.1158/0008-5472.c.6509111.v1
https://doi.org/10.1158/0008-5472.c.6509111.v1
Autor:
Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores Schendel, Maja Bürdek, Susanne Wilde, Daniel Sommermeyer
Publikováno v:
Cancers; Volume 14; Issue 8; Pages: 1998
Cancers 14:1998 (2022)
Cancers 14:1998 (2022)
The hostile tumor microenvironment (TME) is a major challenge for the treatment of solid tumors with T-cell receptor (TCR)-modified T-cells (TCR-Ts), as it negatively influences T-cell efficacy, fitness, and persistence. These negative influences are
Autor:
Luis Felipe Olguín-Contreras, Ramona Schlenker, Heinrich Leonhardt, Elfriede Noessner, Julia Schnappinger, Gerald Willimsky, Susanne Wilde, Svenja Rühland, Matthias Leisegang, Hartmann Harz, Peter J. Nelson, Anja Disovic, Wolfgang Uckert, Dolores J. Schendel
Publikováno v:
Cancer Res. 77, 3577-3590 (2017)
Inherent intermediate- to low-affinity T-cell receptors (TCR) that develop during the natural course of immune responses may not allow sufficient activation for tumor elimination, making the majority of T cells suboptimal for adoptive T-cell therapy
Autor:
Christian Ellinger, Wolfgang Uckert, Elisa Kieback, Felix K.M. Lorenz, Maria Lietz, Susanne Wilde, Dolores J. Schendel
Publikováno v:
Human Gene Therapy
T-cell receptor (TCR) immunotherapy uses T cells engineered with new TCRs to enable detection and killing of cancer cells. Efficacy of TCR immunotherapy depends on targeting antigenic peptides that are efficiently presented by the best-suited major h
Autor:
Thomas Blankenstein, Bruno Kyewski, Sheena Pinto, Dolores J. Schendel, Wolfgang Uckert, Susanne Wilde, Daniel Sommermeyer, Chloé Michel
Publikováno v:
European Journal of Immunology. 44:2811-2821
Immunity to tumor differentiation antigens, such as melanoma antigen recognized by T cells 1 (MART-1), has been comprehensively studied. Intriguingly, CD8(+) T cells specific for the MART-1(26(27)-35) epitope in the context of HLA-A0201 are about 100
Autor:
Bernadette Müller, Ludmila Umansky, Monika Braun, Dominik ter Meer, Joachim W. Ellwart, Barbara Mosetter, Silke Raffegerst, Stefani Spranger, Susanne Wilde, Barbara Simm, Dolores J. Schendel, Christine S. Falk, Tina Lerchl
Publikováno v:
Journal of Innate Immunity. 3:420-434
The CD6 scavenger receptor is known to be expressed on virtually all T cells and is supposed to be involved in costimulation, synapse formation, thymic selection and leukocyte migration. Here, we demonstrate that CD6 is differentially expressed by a
Autor:
Susanne Wilde, Barbara Mosetter, Dolores J. Schendel, Christiane Geiger, Maja Bürdek, Miran Javorovic, Bernhard Frankenberger, Stefani Spranger, Stefanie Tippmer, Iris Bigalke
Publikováno v:
The Journal of Immunology. 185:738-747
In this paper, we describe a new method for preparation of human dendritic cells (DCs) that secrete bioactive IL-12(p70) using synthetic immunostimulatory compounds as TLR7/8 agonists. Monocyte-derived DCs were generated using a procedure that provid
Autor:
Fabio Zani, Frank Thiele, Dirk H. Busch, Gunther Richter, Angela M. Krackhardt, Susanne Wilde, C. Dargel, Michal Bassani-Sternberg, JH Bockmann, Kerstin Stemmer, Matthias Schiemann, Felix Bohne, Dirk Wohlleber, Ulrike Protzer, Karin Wisskirchen, Martin F. Sprinzl, Dolores Schendel, Matthias Mann, Julia Hasreiter, Wolfgang Uckert, Mathias Heikenwalder
Publikováno v:
Gastroenterology 149, 1042-1052 (2015)
Background & Aims Cancer therapies are being developed based on our ability to direct T cells against tumor antigens. Glypican-3 (GPC3) is expressed by 75% of all hepatocellular carcinomas (HCC), but not in healthy liver tissue or other organs. We ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58f94894c66fae0dd33da24d11d1e903
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/90001
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/90001